Citation: | WANG Qi, ZHOU Xiangdong, HAN Zhong, LIU Chang. Effects of expression of activator protein-1 and polytumour activator in tissue of non-small cell lung cancer on prognosis[J]. Journal of Clinical Medicine in Practice, 2021, 25(7): 1-5. DOI: 10.7619/jcmp.20201847 |
[1] |
齐德林, 张毅, 李洪利, 等. Galectin-3在非小细胞肺癌患者血清中的表达及其临床意义[J]. 中国肺癌杂志, 2020, 23(5): 333-336. https://www.cnki.com.cn/Article/CJFDTOTAL-FAIZ202005005.htm
|
[2] |
中国临床肿瘤学会血管靶向治疗专家委员会, 非小细胞肺癌专家委员会, 非小细胞肺癌抗血管生成药物治疗专家组. 晚期非小细胞肺癌抗血管生成药物治疗中国专家共识(2019版)[J]. 中国肺癌杂志, 2019, 22(7): 401-412. https://www.cnki.com.cn/Article/CJFDTOTAL-FAIZ201907001.htm
|
[3] |
肖成, 刘瑧. AP-1与甲状腺癌相关研究进展[J]. 现代肿瘤医学, 2019, 27(6): 1076-1079. doi: 10.3969/j.issn.1672-4992.2019.06.042
|
[4] |
KOO J H, PLOUFFE S W, MENG Z, et al. Induction of AP-1 by YAP/TAZ contributes to cell proliferation and organ growth[J]. Genes Dev, 2020, 34(1/2): 72-86. http://www.researchgate.net/publication/337933153_Induction_of_AP-1_by_YAPTAZ_contributes_to_cell_proliferation_and_organ_growth
|
[5] |
XU Y, NOWRANGI D, LIANG H, et al. DKK3 attenuates JNK and AP-1 induced inflammation via Kremen-1 and DVL-1 in mice following intracerebral hemorrhage[J]. J Neuroinflammation, 2020, 17(1): 130. doi: 10.1186/s12974-020-01794-5
|
[6] |
黄东良, 谢菲岚, 刘璐, 等. PEA3转录因子在恶性肿瘤中的表达及作用[J]. 医学综述, 2019, 25(21): 4223-4227, 4232. doi: 10.3969/j.issn.1006-2084.2019.21.012
|
[7] |
伍培, 黄铧, 秦婷婷, 等. 川崎病患儿外周血MIF/AP-1/MMP-9信号通路的表达及其临床意义[J]. 国际儿科学杂志, 2020, 47(7): 497-502. doi: 10.3760/cma.j.issn.1673-4408.2020.07.014
|
[8] |
WANG Q, YANG S, WANG K, et al. MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer[J]. J Hematol Oncol, 2019, 12(1): 63-74. doi: 10.1186/s13045-019-0759-9
|
[9] |
BODOR J N, BOUMBER Y, BORGHAEI H. Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC)[J]. Cancer, 2020, 126(2): 260-270. doi: 10.1002/cncr.32468
|
[10] |
SUNDQVIST A, VASILAKI E, VOYTYUK O, et al. TGFbeta and EGF signaling orchestrates the AP-1- and p63 transcriptional regulation of breast cancer invasiveness[J]. Oncogene, 2020, 39(22): 4436-4449. doi: 10.1038/s41388-020-1299-z
|
[11] |
ZHU G, CHENG Z, HUANG Y, et al. MyD88 mediates colorectal cancer cell proliferation, migration and invasion via NF-κB/AP-1 signaling pathway[J]. Int J Mol Med, 2020, 45(1): 131-140. http://www.ncbi.nlm.nih.gov/pubmed/31746347
|
[12] |
LI S, UNG T T, NGUYEN T T, et al. Cholic Acid Stimulates MMP-9 in Human Colon Cancer Cells via Activation of MAPK, AP-1, and NF-kappaB Activity[J]. Int J Mol Sci, 2020, 21(10): 3420-3420. doi: 10.3390/ijms21103420
|
[13] |
王熠, 童国强, 计玉兵, 等. 非小细胞肺癌组织中NF-κB、AP-1、TLR2的表达及意义[J]. 癌症进展, 2018, 16(15): 1872-1874. https://www.cnki.com.cn/Article/CJFDTOTAL-AZJZ201815015.htm
|
[14] |
朱春兰, 张梦霞, 何金玉. 卵巢癌组织中多瘤促活化因子、髓样分化因子88的表达与患者浸润、转移的关系[J]. 医疗装备, 2018, 31(9): 22-23. doi: 10.3969/j.issn.1002-2376.2018.09.012
|
[15] |
WANG Y, DING X S, LIU B, et al. ETV4 overexpression promotes progression of non-small cell lung cancer by upregulating PXN and MMP1 transcriptionally[J]. Mol Carcinog, 2020, 59(1): 73-86. doi: 10.1002/mc.23130
|
[16] |
王颖, 刘英宇, 张文艳. TIPE2抑制AP-1蛋白增加人非小细胞肺癌细胞系NCI-H1975化疗敏感性的机制研究[J]. 中国免疫学杂志, 2018, 34(1): 40-43. doi: 10.3969/j.issn.1000-484X.2018.01.008
|